Horizon to use CRISPR tech to enhance CHO cell lines for biomanufacturing – OutSourcing-Pharma.com
OutSourcing-Pharma.comHorizon to use CRISPR tech to enhance CHO cell lines for biomanufacturingOutSourcing-Pharma.comCambridge, UK-based gene editing company Horizon licensed its CRISPR technology from ERS Genomics in 2014 and yesterday announced it ha… Continue reading
